SomaLogic to Present at Morgan Stanley 20th Annual Global Healthcare Conference

Rhea-AI Summary

On August 31, 2022, SomaLogic, a leader in AI-data driven proteomics technology, announced its participation in the Morgan Stanley 20th Annual Global Healthcare Conference in New York. CEO Roy Smythe will host a fireside chat on September 14, 2022, at 12:20 p.m. ET. The event will be accessible via a live and archived webcast on the company’s investor relations website. SomaLogic (Nasdaq: SLGC) focuses on providing actionable health-management information derived from personalized protein measurements, empowering individuals in their health optimization journey.

BOULDER, Colo., Aug. 31, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the upcoming Morgan Stanley 20th Annual Global Healthcare Conference in New York, New York.

Roy Smythe, M.D, SomaLogic’s Chief Executive Officer is scheduled to participate in a fireside chat on Wednesday, September 14, 2022 at 12:20 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.somalogic.com/events-and-presentations.

About SomaLogic
SomaLogic (Nasdaq: SLGC) seeks to deliver precise, meaningful, and actionable health-management information that empowers individuals worldwide to continuously optimize their personal health and wellness throughout their lives. This essential information, to be provided through a global network of partners and users, is derived from SomaLogic’s personalized measurement of important changes in an individual’s proteins over time. For more information, visit www.somalogic.com and follow @somalogic on Twitter.

SomaSignal™ tests are developed and their performance characteristics determined by SomaLogic, Inc. They have neither been cleared or approved by the US Food and Drug Administration. SomaLogic operates a Clinical Laboratory Improvement Amendments (CLIA) certified, and College of American Pathologists (CAP) accredited laboratory.

Investor Contact
Lauren Glaser
lglaser@somalogic.com

Marissa Bych
Gilmartin Group LLC
marissa@gilmartinir.com

Media Contact
Emilia Costales
720-798-5054
ecostales@somalogic.com

FAQ

When is SomaLogic's presentation at the Morgan Stanley Global Healthcare Conference?

SomaLogic's presentation is scheduled for September 14, 2022, at 12:20 p.m. Eastern Time.

Where can I watch SomaLogic's presentation live?

You can access a live webcast of SomaLogic's presentation on their investor relations website.

What is the focus of SomaLogic, Inc.?

SomaLogic focuses on delivering meaningful health-management information through personalized protein measurements.

What stock symbol represents SomaLogic?

SomaLogic is listed under the stock symbol SLGC.